Welcome to the LAL-D Patient Organization (LAL-D PO), the international organization for patients and families affected by Lysosomal Acid Lipase Deficiency (LAL-D).
Our goal is to support families, raise awareness of the disease, advance research, and promote early diagnosis, which is key to saving lives and improving patients’ quality of life.
Since 2015, we have been working to ensure that no one affected by LAL-D feels alone.
TRPM2, TFEB and LAL: A New Link
New Research Identifies a Pathway Regulating Lysosomal Acid Lipase (LAL) Activity and Lysosomal Health Research into lysosomal diseases continues to advance, providing new insights into the cellular mechanisms that maintain metabolic balance. A recent study...
The Importance of Early Diagnosis in Wolman Disease
New Publication Expands Knowledge of Wolman Disease and Reports a Novel LIPA Variant A recent article published in Frontiers in Pediatrics reports on two Chinese infants diagnosed with Wolman Disease, the most severe infantile form of Lysosomal Acid Lipase...
Research and Hope for LAL-D
New Research Project Explores Innovative Strategies for Lysosomal Acid Lipase Deficiency (LAL-D) At LAL-D Patient Organization, we would like to congratulate Matthias Zadory on the successful defense of his doctoral thesis, “Engineering Non-Viral Gene...
